MICHAEL KRANDA

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: KRANDA

Related Companies
Titles
Company Name
Related People
DIRECTOR
PTC THERAPEUTICS, INC.
RICHARD ALDRICH, NEIL ALMSTEAD, NEIL ALMSTEAD, PH.D, WILLIAM BAIRD, III, AXEL BOLTE, MARK E. BOULDING, SOREN CARLSEN, CARL GOLDFISCHER, EMILY HILL, CLAUDIA HIRAWAT, ALLAN S. JACOBSON, ALLAN JACOBSON, PH.D., MATTHEW KLEIN, MATTHEW B. KLEIN, MATTHEW B. KLEIN, M.D., ADAM KOPPEL, GEOFFREY MCDONOUGH, LANGDON L. MILLER, LANGON L. MILLER, STEPANIE S. OKEY, STEPHANIE S. OKEY, DEEPA PAKIANATHAN, ERIC PAUWELS, STUART W. PELTZ, EMMA REEVE, MICHAEL SCHMERTZLER, MARY SMITH, DAVID P. SOUTHWELL, MARCIO SOUZA, GLENN D. STEELE JR., M.D., PH.D., GLENN D. STEELE, JR., PETER SVENNILSON, DAWN SVORONOS, CHRISTINE UTTER, ALETHIA YOUNG, JEROME B. ZELDIS, JEROME B. ZELDIS, M.D., PH.D.
EXECUTIVE OFFICER, DIRECTOR
VACCINOGEN INC
GREGORY H. BARNHILL, TONY CAPLIN, ALAN COHEN, HAKAN EDSTROM, DAN FITZGERALD, DANIEL FITZGERALD, MICHAEL HAGERMAN, ANDERS HALLDIN, MICHAEL G. HANNA, JR., DAVID HATT, RONALD KAISER, DANIEL KANE, MICHAEL L. KRANDA, JOHN NICOLIS, ANDREW L. TUSSING
EXECUTIVE OFFICER, DIRECTOR
BEAT BIOTHERAPEUTICS CORP
JIM LEGGETT, GREG MAHAIRAS, PH.D., CRAIG TALL
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TWINSTRAND BIOSCIENCES, INC.
RONNIE ANDREWS, CHRISTOPHER BENOIT, KELLIE BICKEL, DAVID CANNER, ELENA CANT, KAREN DABBS, STEVE DOW, MICHELE FERNANDES, CHRIS IGIELSKI, LAWRENCE LOEB, JASON MYERS, TERRY MYERSON, MICHAEL PELLINI, MIKE PELLINI, LINDEN RHOADS, JESSE SALK, MICHAEL SCHMITT, SOMA SOMASEGAR, CHAD WAITE, CHAD WAITE, JR.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-10 
2013-05-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-05-14 
2013-04-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-04-08 
2013-03-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-03-07 
2013-02-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-01-29 
2012-06-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-29 
2010-10-14
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-09-04 
2009-12-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2009-12-22 
2009-10-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
 
2009-09-22